A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Probable Benefit of the KeraKlear Non-Penetrating Keratoprosthesis in Subjects With Corneal Opacity With Poor Prognosis for Corneal Transplant
To evaluate the safety and probable benefit of the KeraKlear Non-Penetrating Keratoprosthesis when implanted in an eye with corneal opacity that is at high risk of complications with PK.
100 Clinical Results associated with KeraMed, Inc.
0 Patents (Medical) associated with KeraMed, Inc.
100 Deals associated with KeraMed, Inc.
100 Translational Medicine associated with KeraMed, Inc.